CD47 expression is decreased in hematopoietic progenitor cells in patients with myelofibrosis by A. Nonino (6072632)

“…We compared CD47 expression in hematopoietic stem and progenitor cells of patients with MF and controls and found it to be decreased in progenitors of MF. …”

Loss of Prox1a decreases PR production at 120 hours post-ablation. by Kellie Veen (17343374)

GSK343 decreased tumor stemness. by Laura V. Bownes (10276762)

“…Treatment with GSK343 significantly decreased tumorsphere formation by both the COA3 (A) and COA6 (B) cells, representing a decrease in stem cell-like phenotype. …”

Decreased Bone Mineral Density Is an Independent Predictor for the Development of Atherosclerosis: A Systematic Review and Meta-Analysis by Chenyi Ye (2697208)

“…</p><p>Results</p><p>A total of 25 studies involving 10,299 patients were included. …”

Antagomir-25 injection resulted in decreased proliferation of NSCs 7days after tMCAO. by Feng Guo (180529)

Rapamycin decreases Schwann cell markers, whereas statin induces Schwann cell markers. by Andrea Preitschopf (629851)

CCN3 protein decreases β-cell proliferation. by Renée Paradis (326111)

<i>Nanos1</i>⁺ cells in the bulb decrease after X-ray irradiation or drug treatments. by Sosuke Fujita (17691623)

The PRAME-AS knockout cells showed a decrease in migration, proliferation, stemness, and viability. by Zahra Hosseininia (22265113)

Data_Sheet_1_Botulinum toxin A decreases neural activity in pain-related brain regions in individuals with chronic ocular pain and photophobia.docx by Nicholas Reyes (16390233)

“…On an individual level, 50% of subjects had decreased unpleasantness ratings in response to light stimulation compared to baseline (“responders,” n = 6), while 50% had equivalent (n = 3) or increased (n = 3) unpleasantness (“non-responders”). …”

Therapeutic administration of hMSCs failed to decrease pulmonary inflammation or modify BAL inflammatory cell counts in experimental severe influenza. by Ilyse Darwish (446378)

Therapeutic administration of mMSCs failed to decrease pulmonary inflammation or modify BAL inflammatory cell counts in experimental severe influenza. by Ilyse Darwish (446378)

MSCs decrease oligodendrocyte death. by Justin D. Glenn (800439)

Time allocation may not decrease with price for a non-linear microscopic utility of leisure. by Ritwik K. Niyogi (427932)

“…We normalised by the trial duration of 25 price, instead of simply normalizing by the price, to emphasise that <i>TA</i> is a macroscopic quantitity and to be consistent with the procedure in the example data <a href="http://www.ploscompbiol.org/article/info:doi/10.1371/journal.pcbi.1003894#pcbi.1003894.s001" target="_blank">Figure S1</a>.…”

hMSC adjunctive therapy failed to decrease pulmonary inflammation or prevent ALI compared to antiviral therapy alone in experimental severe influenza. by Ilyse Darwish (446378)

“…<p>Eight-week old male C57Bl/6 mice infected with 425 EID₅₀ influenza A/PR/8 virus were administered 2.5 mg/kg oseltamivir in 100 ul ddH2O via gavage, 1×daily for 5 days, beginning day 2 P.I., with or without hMSC administration (5×10⁵ cells) on day 2 P.I. and sacrificed on day 7 P.I. …”

siRNA-mediated APP-BP1 knock-down significantly decreases BrdU-incorporated fetal neural stem cells. by Yuyoung Joo (236048)

MiR-24 is required for blood development from mouse embryonic stem cells. by Lynn Roy (687524)

Subjects:

Targeted knockdown of p63γ variants decreased the mRNA expression of VDR, osterix, runx2 and osteopontin. by Kevin M. Curtis (718103)

Prolonged treatment with propofol does not decrease the neural stem cell pool. by Arvind Palanisamy (3159156)

Propofol induced cell death and decreased mitochondrial membrane potential in a concentration- and time-dependent manner. by Chisato Sumi (3521705)